Xconomy: Anemia News, Articles and Opinions

“anemia” Archives

Entry	Author	Date	Location
Celgene Files for FDA Approval of Blood Disease Drug	Frank Vinluan	04/05/19	New York
Bio Roundup: 2019 Trials, Pilgrim Price Chat, Pre-Xmas Sales & More	Alex Lash	12/21/18	National
With New Results, FibroGen’s Anemia Pill Inches Closer to FDA Review	Ben Fidler	12/20/18	San Francisco
Acceleron, Celgene Drug Shines in Phase 3 Test in Rare Blood Disorder	Frank Vinluan	07/09/18	Boston
Akebia Merges With Keryx as Anemia Drug Race Nears Finish Line	Ben Fidler	06/28/18	Boston
For Sickle Cell, a Complex Disease, New Drugs Could Bring Complex Costs	Alex Lash	06/15/18	San Francisco
15 For ’18: Key Clinical Data to Watch For Next Year (Part 1)	Ben Fidler	12/04/17	National
Bio Roundup: Travel Ban, Pharma in DC, Biogen Splits, PCSK9 Wins	Ben Fidler	02/03/17	National
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits	Ben Fidler	01/30/17	San Francisco
Akebia Gets $265M From Otsuka to Bankroll Anemia Drug Push	Ben Fidler	12/20/16	Boston
Bio Roundup: NY Rises, Prez Inks Cures, Ophthotech Crashes & More	Alex Lash	12/16/16	National
Bay Area Researchers Take A CRISPR Cut At Sickle Cell Disease	Alex Lash	10/12/16	San Francisco
Roundup: Owlchemy, TheWaveVR, Fe3 Medical, & Rackspace Buyout?	Angela Shah	08/09/16	Texas
Texas Government Adds $3.5M to Fe3 Series B for Anemia Treatment	David Holley	08/08/16	Texas
After Rival Stumbles, Relypsa Gets $1.5B Buyout Bid From Galenica	Ben Fidler	07/21/16	San Francisco
Anemia Ups and Downs: Agios Hit On One Drug, Touts Data For Another	Ben Fidler	06/11/16	Boston
East Coast Biotech Roundup: Celldex, Ensemble, CRISPR Battle & More	Ben Fidler	03/10/16	Boston
InCube Labs Startup Fe3 Plans Iron-Delivering Patch For Anemia	David Holley	03/04/16	Texas
With New Data, Highs and Lows For Akebia, Flexion, Tetraphase	Ben Fidler	09/08/15	Boston
Global Blood Thera Nabs $120M IPO, Doubles Share Price On First Day	Alex Lash	08/11/15	San Francisco
Amag Seeks New Chapter With $700M Cord Blood Registry Purchase	David Holley	06/30/15	Boston
Celgene, Versant Shake Again, Cut $30M Deal For Toronto Biotech	Alex Lash	04/29/15	New York
With Celiac Deal, Celimmune Aims to Give New Life to Old Amgen Drug	Ben Fidler	03/02/15	New York
As Rival Sputters, FibroGen Heads to Nasdaq Via $146M IPO	Ben Fidler	11/14/14	San Francisco
East Coast Biotech Roundup: Sarepta, Aegerion, Syros, Aileron & More	Ben Fidler	10/31/14	Boston
West Coast Biotech Roundup: Amgen, Inslee, Fibrogen, Receptos & More	Alex Lash	10/30/14	Seattle
G1, Out to Shield Body From Chemo, Heads to First Clinical Test	Ben Fidler	07/28/14	Raleigh Durham
How a Little Serendipity Led Acceleron to a Crippling Blood Disease	Ben Fidler	07/17/14	Boston
West Coast Biotech Roundup: Affymax, K2, Roche/Stratos, & More	Alex Lash	06/26/14	San Francisco
Bluebird’s Gene Therapy Quickly Halts Blood Disease in Small Study	Ben Fidler	06/14/14	Boston
Page 1 of 3	next page »